Pharmacokinetics and Tolerability of Duloxetine following Oral Administration to Healthy Chinese Subjects

被引：0
|
作者：
Si Tianmei
Mary Pat Knadler
Ming T. Lim
Kwee Poo Yeo
Leyan Teng
Shu Liang
Alan X. Pan
Evelyn D. Lobo
机构：
[1] Peking University Institute of Mental Health,Drug Disposition
[2] Eli Lilly and Company,Lilly
[3] Natlonal University of Singapore,NUS Centre for Clinical Pharmacology
[4] Global Pharmacokinetic/Pharmacodynamic/Trial Simulation,Eli Lilly and Company, Drug Disposition
来源：
Clinical Pharmacokinetics | 2007年 / 46卷
关键词：
Multiple Dose; Duloxetine; CYP1A2 Activity; Intermediate Metabolisers; Japanese Subject;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：767 / 775
页数：8
相关论文
共 50 条
  • [21] Pharmacokinetics and Safety of Vedolizumab Following Administration of a Single Intravenous Dose in Healthy Chinese Subjects
    Xie, Ran
    Zhao, Nan
    Jia, Bo
    Zhao, Xia
    Cui, Yimin
    Okamoto, Hiroyuki
    Yang, Lili
    Prokopienko, Alexander
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (01) : 35 - 40
  • [22] PHARMACOKINETICS OF KETANSERIN IN HEALTHY-SUBJECTS FOLLOWING INTRAVENOUS, INTRAMUSCULAR AND ORAL-ADMINISTRATION
    VANPEER, A
    HEYKANTS, J
    WOESTENBORHGS, R
    EMBRECHTS, L
    GASPARINI, R
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1985, 274 (02): : 332 - 333
  • [23] PHARMACOKINETICS OF DGAVP IN PLASMA FOLLOWING INTRANASAL AND ORAL-ADMINISTRATION TO HEALTHY-SUBJECTS
    WESTENBERG, HGM
    HIJMAN, R
    WIEGANT, VM
    LACZI, F
    VANREE, JM
    PEPTIDES, 1994, 15 (06) : 1101 - 1104
  • [24] Pharmacokinetics and Safety of Vedolizumab Following Administration of a Single Intravenous Dose in Healthy Chinese Subjects
    Ran Xie
    Nan Zhao
    Bo Jia
    Xia Zhao
    Yimin Cui
    Hiroyuki Okamoto
    Lili Yang
    Alexander Prokopienko
    European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 35 - 40
  • [25] EFFECT OF FOOD ON THE PHARMACOKINETICS OF CYCLOSPORINE IN HEALTHY-SUBJECTS FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION
    GUPTA, SK
    MANFRO, RC
    TOMLANOVICH, SJ
    GAMBERTOGLIO, JG
    GAROVOY, MR
    BENET, LZ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (07): : 643 - 653
  • [26] Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
    Beibei Liang
    Jin Wang
    Guanxuanzi Zhang
    Rui Wang
    Yun Cai
    Neurology and Therapy, 2023, 12 : 947 - 959
  • [27] Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects
    Suri, A
    Reddy, S
    Gonzales, C
    Knadler, MP
    Branch, RA
    Skinner, MH
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (02) : 78 - 84
  • [28] Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
    Liang, Beibei
    Wang, Jin
    Zhang, Guanxuanzi
    Wang, Rui
    Cai, Yun
    NEUROLOGY AND THERAPY, 2023, 12 (03) : 947 - 959
  • [29] Tolerability, Pharmacokinetics, and Pharmacodynamics of Galcanezumab in Healthy Subjects Following a Subcutaneous Administration of a Lyophilized Formulation or a Solution Formulation
    Kielbasa, W.
    Williams, D. W.
    Coutant, D. E.
    King, A.
    Ayan-Oshodi, M. A.
    HEADACHE, 2017, 57 : 138 - 138
  • [30] Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects
    Liu, Yun
    Tomlinson, Brian
    Guo, Jiyuan
    Asghamejad, Mahnaz
    Bauer, Lars
    Surmann, Erwin
    Guo, Xiaojuan
    Elshoff, Jan-Peer
    CLINICAL THERAPEUTICS, 2018, 40 (07) : 1108 - 1121
12345